SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001557142-21-000070
Filing Date
2021-08-05
Accepted
2021-08-05 16:27:32
Documents
71
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q kdmn-20210630x10q.htm   iXBRL 10-Q 3376255
2 EX-31.1 kdmn-20210630xex31_1.htm EX-31.1 20190
3 EX-31.2 kdmn-20210630xex31_2.htm EX-31.2 20533
4 EX-32.1 kdmn-20210630xex32_1.htm EX-32.1 10191
5 EX-32.2 kdmn-20210630xex32_2.htm EX-32.2 10072
  Complete submission text file 0001557142-21-000070.txt   11497071

Data Files

Seq Description Document Type Size
6 EX-101.SCH kdmn-20210630.xsd EX-101.SCH 42355
7 EX-101.CAL kdmn-20210630_cal.xml EX-101.CAL 60980
8 EX-101.DEF kdmn-20210630_def.xml EX-101.DEF 207318
9 EX-101.LAB kdmn-20210630_lab.xml EX-101.LAB 387654
10 EX-101.PRE kdmn-20210630_pre.xml EX-101.PRE 359733
11 EXTRACTED XBRL INSTANCE DOCUMENT kdmn-20210630x10q_htm.xml XML 2649856
Mailing Address 450 EAST 29TH STREET NEW YORK NY 10016
Business Address 450 EAST 29TH STREET NEW YORK NY 10016 833-900-5366
Kadmon Holdings, Inc. (Filer) CIK: 0001557142 (see all company filings)

IRS No.: 273576929 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37841 | Film No.: 211148705
SIC: 2834 Pharmaceutical Preparations